PubMed · 2866839
Beta-adrenergic blockade. An update.
Abstract
beta-Adrenergic blockade represents a major pharmacologic advance. These drugs bind to membrane adrenergic receptors interfering with the effects of endogenous catecholamines. Eight beta-blockers are available in the United States, and others are being studied. The drugs have varying pharmacodynamic properties that may modify certain side effects: beta 1-selectivity, partial agonism, alpha-adrenergic blocking activity, membrane stabilization, and varying pharmacokinetic characteristics. The drugs have been shown to be relatively safe and useful for a wide variety of cardiovascular and noncardiovascular disease states, and their wide spectrum of therapeutic activity illustrates the importance of the sympathetic nervous system in the pathophysiology of medical illness.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
W H Frishman, M Teicher. 1985. Beta-adrenergic blockade. An update.. https://doi.org/10.1159/000173885
Cite the original work for its findings. Save a collection to share your selection of sources.